Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
In blow to compounders, FDA reaffirms tirzepatide shortage is over The FDA has reaffirmed that the shortage of Eli Lillys blockbuster obesity and diabetes medications is resolved, dealing a blow to pharmacies and telehealth services Sign up to read this article for free
The fear was louder than the evidence supported
The company, through its Lemonaid Health business, plans to launch a GLP-1 weight loss telehealth membership by the end of the month, it announced last week along with its fiscal first-quarter financial results
When expectations and outcomes dont align, it can feel like the treatment isnt working, even when it may be having a meaningful effect
Safety endpoints included AEs and safety laboratory parameters
US$ 22.65
US$ 28.19
US$ 23.45
